Saol Therapeutics (Baclofen Franchise, Lioresal and Lyvispahtm) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Saol Therapeutics (Baclofen Franchise, Lioresal and Lyvispahtm) General Information

Description

Portfolio of baclofen, lioresal and lyvispahtm a pipeline product under development.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Roswell, GA
  • United States
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Drug Discovery
Acquirer
Amneal Pharmaceuticals
Corporate Office
  • Roswell, GA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Saol Therapeutics (Baclofen Franchise, Lioresal and Lyvispahtm) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Saol Therapeutics (Baclofen Franchise, Lioresal and Lyvispahtm)‘s full profile, request access.

Request a free trial

Saol Therapeutics (Baclofen Franchise, Lioresal and Lyvispahtm) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Saol Therapeutics (Baclofen Franchise, Lioresal and Lyvispahtm)‘s full profile, request access.

Request a free trial

Saol Therapeutics (Baclofen Franchise, Lioresal and Lyvispahtm) FAQs

  • Where is Saol Therapeutics (Baclofen Franchise, Lioresal and Lyvispahtm) headquartered?

    Saol Therapeutics (Baclofen Franchise, Lioresal and Lyvispahtm) is headquartered in Roswell, GA.

  • What industry is Saol Therapeutics (Baclofen Franchise, Lioresal and Lyvispahtm) in?

    Saol Therapeutics (Baclofen Franchise, Lioresal and Lyvispahtm)’s primary industry is Buildings and Property.

  • Is Saol Therapeutics (Baclofen Franchise, Lioresal and Lyvispahtm) a private or public company?

    Saol Therapeutics (Baclofen Franchise, Lioresal and Lyvispahtm) is a Private company.

  • What is the current valuation of Saol Therapeutics (Baclofen Franchise, Lioresal and Lyvispahtm)?

    The current valuation of Saol Therapeutics (Baclofen Franchise, Lioresal and Lyvispahtm) is .

  • What is Saol Therapeutics (Baclofen Franchise, Lioresal and Lyvispahtm)’s current revenue?

    The current revenue for Saol Therapeutics (Baclofen Franchise, Lioresal and Lyvispahtm) is .

  • Who are Saol Therapeutics (Baclofen Franchise, Lioresal and Lyvispahtm)’s investors?

    Saol Therapeutics has invested in Saol Therapeutics (Baclofen Franchise, Lioresal and Lyvispahtm).

  • When was Saol Therapeutics (Baclofen Franchise, Lioresal and Lyvispahtm) acquired?

    Saol Therapeutics (Baclofen Franchise, Lioresal and Lyvispahtm) was acquired on 05-Jan-2022.

  • Who acquired Saol Therapeutics (Baclofen Franchise, Lioresal and Lyvispahtm)?

    Saol Therapeutics (Baclofen Franchise, Lioresal and Lyvispahtm) was acquired by Amneal Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process